REVEN PHARMACEUTICALS Trademark

Trademark Overview

On Wednesday, May 13, 2015, a trademark application was filed for REVEN PHARMACEUTICALS with the United States Patent and Trademark Office. The USPTO has given the REVEN PHARMACEUTICALS trademark a serial number of 86628046. The federal status of this trademark filing is REGISTERED as of Tuesday, February 26, 2019. This trademark is owned by Reven Pharmaceuticals, Inc.. The REVEN PHARMACEUTICALS trademark is filed in the Computer & Software Services & Scientific Services category with the following description:

Pharmaceutical research and development in the fields of cardiovascular disease, vascular therapy, skin conditions, diabetic conditions, cancer, infectious disease, sports enhancement, nerve system disease, brain disease and mitochondrial disease; Pharmaceutical services, namely, the development of pharmaceuticals for the treatment of cardiovascular disease, vascular therapy, skin conditions, diabetic conditions, cancer, infectious disease, sports enhancement, nerve system disease, brain disease and mitochondrial disease
reven pharmaceuticals

General Information

Serial Number86628046
Word MarkREVEN PHARMACEUTICALS
Filing DateWednesday, May 13, 2015
Status700 - REGISTERED
Status DateTuesday, February 26, 2019
Registration Number5686422
Registration DateTuesday, February 26, 2019
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, October 27, 2015

Trademark Statements

Translation of Words in MarkThe wording "REVEN" has no meaning in a foreign language.
Disclaimer with Predetermined Text"PHARMACEUTICALS"
Goods and ServicesPharmaceutical research and development in the fields of cardiovascular disease, vascular therapy, skin conditions, diabetic conditions, cancer, infectious disease, sports enhancement, nerve system disease, brain disease and mitochondrial disease; Pharmaceutical services, namely, the development of pharmaceuticals for the treatment of cardiovascular disease, vascular therapy, skin conditions, diabetic conditions, cancer, infectious disease, sports enhancement, nerve system disease, brain disease and mitochondrial disease

Classification Information

International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateWednesday, May 20, 2015
Primary Code042
First Use Anywhere DateFriday, December 21, 2018
First Use In Commerce DateFriday, December 21, 2018

Trademark Owner History

Party NameReven Pharmaceuticals, Inc.
Party Type30 - Original Registrant
Legal Entity Type03 - Corporation
AddressGolden, CO 80401
Party NameReven Pharmaceuticals, Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressGolden, CO 80401
Party NameReven Pharmaceuticals, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressGolden, CO 80401

Trademark Events

Event DateEvent Description
Monday, February 26, 2024COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
Tuesday, February 26, 2019REGISTERED-PRINCIPAL REGISTER
Thursday, January 24, 2019NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
Wednesday, January 23, 2019ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
Wednesday, January 9, 2019STATEMENT OF USE PROCESSING COMPLETE
Monday, December 24, 2018USE AMENDMENT FILED
Wednesday, December 26, 2018TEAS STATEMENT OF USE RECEIVED
Tuesday, June 26, 2018NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, June 25, 2018SOU EXTENSION 5 GRANTED
Friday, June 22, 2018SOU EXTENSION 5 FILED
Monday, June 25, 2018CASE ASSIGNED TO INTENT TO USE PARALEGAL
Friday, June 22, 2018SOU TEAS EXTENSION RECEIVED
Saturday, December 23, 2017NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, December 21, 2017SOU EXTENSION 4 GRANTED
Thursday, December 21, 2017SOU EXTENSION 4 FILED
Thursday, December 21, 2017SOU TEAS EXTENSION RECEIVED
Saturday, June 24, 2017NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, June 22, 2017SOU EXTENSION 3 GRANTED
Thursday, June 22, 2017SOU EXTENSION 3 FILED
Thursday, June 22, 2017SOU TEAS EXTENSION RECEIVED
Saturday, December 24, 2016NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, December 22, 2016SOU EXTENSION 2 GRANTED
Thursday, December 22, 2016SOU EXTENSION 2 FILED
Thursday, December 22, 2016SOU TEAS EXTENSION RECEIVED
Friday, June 24, 2016NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, June 22, 2016SOU EXTENSION 1 GRANTED
Wednesday, June 22, 2016SOU EXTENSION 1 FILED
Wednesday, June 22, 2016SOU TEAS EXTENSION RECEIVED
Tuesday, December 22, 2015NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, October 27, 2015OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, October 27, 2015PUBLISHED FOR OPPOSITION
Wednesday, October 7, 2015NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Friday, September 18, 2015LAW OFFICE PUBLICATION REVIEW COMPLETED
Thursday, September 17, 2015ASSIGNED TO LIE
Friday, August 21, 2015APPROVED FOR PUB - PRINCIPAL REGISTER
Friday, August 21, 2015EXAMINER'S AMENDMENT ENTERED
Friday, August 21, 2015NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Friday, August 21, 2015EXAMINERS AMENDMENT E-MAILED
Friday, August 21, 2015EXAMINERS AMENDMENT -WRITTEN
Wednesday, August 19, 2015ASSIGNED TO EXAMINER
Wednesday, May 20, 2015NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Saturday, May 16, 2015NEW APPLICATION ENTERED

Related Keywords

pharmaceuticals reven disease conditions enhancement infectious sports nerve mitochondrial brain system pharmaceutical